Latest Filings

Issuer Activity

Insider Overview :: Verisante Technology, Inc. (V:VRS) [?]
Business Focus: Advanced Medical Equipment & Technology Share on StockTwits
Log in or sign up for a free account to add this stock to your watch list.

Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET March 30th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET March 30th, 2015
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for VRS on March 30, 2015 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEDAR
Key People
Thomas A. Braun
President, Chief Executive Officer, Chief Business Development Officer, Director
Anna Trinh
Chief Financial Officer, Vice President - Administration, Corporate Counsel, Secretary
 
Company Contact
Address: 306-2309 41st Ave W
VANCOUVER BC V6M 2A3
Tel: N/A
Website: www.verisante.com
IR: See website
Business Overview
Verisante Technology, Inc. is a Canada-based medical device company. The Company is engaged in commercializing systems for the early detection of cancer. The Company's device portfolio includes Verisante Aura, Verisante Core and Verisante MSI Camera. Verisante Aura is a Raman spectroscopy system, designed for the early detection of all forms of skin cancer, including basal cell and squamous cell carcinoma and melanoma. The system provides diagnosis information by identifying spectral changes associated with the biochemistry of skin cancer cells in less than a second; providing immediate results. The Verisante Core is a medical equipment for the early detection of cancers including lung, colon and cervical, using an endoscopic attachment. Verisante MSI Camera is a rapid MSI imaging system, which captures images of 18 different narrow band wavelengths of light in one third of a second to capture multispectral images, which assist in oral and skin cancer detection applications.
Financial Overview
For the nine months ended 30 September 2014, Verisante Technology Inc revenues decreased 82% to C$153K. Net loss decreased 20% to C$2.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Professional fees decrease of 38% to C$402K (expense), Salaries decrease of 20% to C$606K (expense), Promotional costs decrease of 49% to C$82K (expense).
Employees: 8 as of Mar 31, 2009
Reporting Currency: Canadian Dollars
Enterprise value: $8.56M as of Sep 30, 2014
Annual revenue (TTM): $0.07M as of Sep 30, 2014
EBITDA (TTM): -$3.13M as of Sep 30, 2014
Net annual income (TTM): -$4.27M as of Sep 30, 2014
Free cash flow (TTM): -$1.59M as of Sep 30, 2014
Net Debt Last Fiscal Year: N/A
Shares outstanding: 90,187,006 as of Mar 10, 2015
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization
Competitors with Recent Insider Filings
Titan Medical (T:TMD)
Zecotek Photonics (V:ZMS)
IMRIS (T:IM)
 
Verisante Technology, Inc. Insider Report Only $20.00